ITEOS THERAPEUTICS INC's ticker is ITOS and the CUSIP is 46565G104. A total of 84 filers reported holding ITEOS THERAPEUTICS INC in Q2 2021. The put-call ratio across all filers is - and the average weighting 0.5%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $269,710 | -7.7% | 24,631 | +11.6% | 0.00% | – |
| Q2 2023 | $292,326 | -73.6% | 22,079 | -72.8% | 0.00% | -100.0% |
| Q1 2023 | $1,105,417 | -23.5% | 81,221 | +9.8% | 0.00% | 0.0% |
| Q4 2022 | $1,445,318 | +363.2% | 74,005 | +352.0% | 0.00% | – |
| Q3 2022 | $312,000 | -97.5% | 16,372 | -97.3% | 0.00% | -100.0% |
| Q2 2022 | $12,357,000 | -43.8% | 599,831 | -12.2% | 0.01% | -30.0% |
| Q1 2022 | $21,973,000 | +3748.2% | 682,802 | +5465.3% | 0.01% | – |
| Q4 2021 | $571,000 | -69.9% | 12,269 | -82.5% | 0.00% | -100.0% |
| Q3 2021 | $1,895,000 | +4.6% | 70,167 | -0.6% | 0.00% | 0.0% |
| Q2 2021 | $1,811,000 | -26.0% | 70,584 | -1.5% | 0.00% | 0.0% |
| Q1 2021 | $2,448,000 | +806.7% | 71,627 | +798.3% | 0.00% | – |
| Q4 2020 | $270,000 | +91.5% | 7,974 | +39.7% | 0.00% | – |
| Q3 2020 | $141,000 | – | 5,707 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| MPM ASSET MANAGEMENT LLC | 2,738,785 | $37,274,864 | 15.53% |
| MPM BioImpact LLC | 1,745,943 | $23,762,284 | 6.17% |
| Saturn V Capital Management LP | 480,653 | $6,541,687 | 4.89% |
| Boxer Capital, LLC | 2,154,058 | $29,317 | 1.44% |
| RA Capital Management | 4,417,259 | $60,118,895 | 1.36% |
| Octagon Capital Advisors LP | 596,000 | $8,111,560 | 1.17% |
| BVF INC/IL | 1,810,835 | $24,645,464 | 0.90% |
| AlphaCentric Advisors LLC | 63,000 | $857,430 | 0.59% |
| Integral Health Asset Management, LLC | 180,000 | $2,449,800 | 0.49% |
| 683 Capital Management, LLC | 480,000 | $6,532,800 | 0.49% |